Ulcer benign

Chronic peptic ulcer (benign ulcer) a. Peptic ulcer... 

Nizatidine, a histamine-receptor antagonist (300 mg once daily at bedtime), is indicated in the management of duodenal ulcer, benign gastric ulcer, and gastroesophageal reflux disease (see also Table 10). 

CEA levels are elevated in benign diseases such as inflammatory bowel disease, chronic gastritis and peptic ulcer, cirrhosis, and hepatitis. CEA testing is recommended primarily to monitor patients after surgery for recurrent colorectal carcinoma. Twenty percent of colorectal carcinomas do not express CEA therefore, immunohistochemical methods are recommended to identify the negative cases. If a 5.0 ng/ml cutoff is used as the detection criterion, approximately 60 to 90 percent of the clinical cases will be detected for recurrences 2 to 10 months prior to clinical symptoms (37, 38). 

Active benign gastric ulcer- For short-term treatment, 800 mg at bedtime or 300 mg 4 times/day with meals and at bedtime. 

Benign gastric ulcer- 300 mg given either as 150 mg twice daily or 300 mg once daily at bedtime. 

Contraindications Angle-closure glaucoma, benign prostatichyperplasia, GI obstruction, intestinal atony, megacolon, myasthenia gravis, paralytic ileus, severe ulcerative colitis... 

Active benign gastric ulcer PO 150 mg twice a day or 300 mg at bedtime. Dyspepsia PO 75 mg 30-60 min before meals no more than 2 tablets a day. Dosage In renal impairment Dosage adjustment is based on creatinine clearance. 

Unlabeled Uses H. pytori-associated duodenal ulcer (wifh amoxicillin and clarilhro-mycin), prevenfion and treatment of NSAID-induced ulcers, frealmenf of acfive benign gastric ulcers... 

Ulcerative stomatitis (erythema or ulcers of oral mucosa, glossitis, gingivitis), pneumonia, and benign skin neoplasms occur occasionally. 

Short-term treatment of active benign gastric ulcer... 

Combination therapy for H. Pylori eradication to reduce the risk of duodenal ulcer recurrence—30 mg 2 to 3 times daily for 10 to 14 days Maintenance of healed duodenal ulcers—15 mg once daily Short-term treatment of active benign gastric ulcers—30 mg once daily for up to 8 weeks... 

The author commented that 50-75% of gastrocolic fistulas are related to benign gastric ulcers secondary to the use of NSAIDs. The use of aspirin plus prednisone, as in this patient, increases the risk of complication of peptic ulcer disease two- to fourfold. 

Bismuth chelate is used for benign gastric and duodenal ulcer and has a therapeutic efficacy approximately equivalent to histamine receptor antagonists. Ulcers remain healed for longer after bismuth chelate than after the histamine receptor antagonists, and this may relate to the ability of the former but not the latter to eradicate Helicobacter pylori. 

Aspirin can also play a role in esophageal bleeding, ulceration, or benign stricture, and it should be considered as a possible cause in patients, particularly the elderly, who present with any of these features. There have also been reports of rectal stricture in the elderly, associated with the use of aspirin suppositories. Effects on both these strictures emphasize the significance of a direct local action of aspirin as well as a systemic action and underlines the relevance of the involvement of oxygen-derived free radicals in the pathogenesis of mucosal lesions in the gastrointestinal tract (54-56). 

Injection-site reactions are common after subcutaneous injection of interferon beta-lb, and are more frequent than with any other available interferons. In a multicenter placebo-controUed trial, 65% of patients receiving interferon beta-lb had reactions at the injection site compared with 6% in the placebo group (2). In contrast, only 5% of those who received interferon beta-la had injection site reactions (3). The clinical features of injection site reactions to interferon beta-lb mostly consist of benign inflammatory reactions, but they can sometimes be more severe, with sclerotic dermal plaques, painful erythematous nodules, and deep cutaneous ulcers with skin necrosis (SEDA-21,... 

In 163 patients with endoscopically proven benign gastric ulcers randomly allocated to telenzepine 3 mg/day or... 

Treatment of H. py/ori-associated duodenal ulcer (with amoxicillin, clarithromycin), active benign gastric ulcers. Prevention/ treatment of NSAID-induced ulcers. 

Acute therapy benign gastric ulcer PO 40 mg at bedtime... 

---